Navigation Links
China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates
Date:5/15/2009

5,807,277 Operating expenses: Selling expenses 602,760 337,792 General and administrative expenses 488,047 342,818 Bad debt expense 774,932 472,975 Total operating expenses 1,865,739 1,153,585 Income from operations 4,063,016 4,653,692 Non-operating income (expenses): Interest income 10,589 -- Interest expense (38,236) (45,273) Total non-operating income (expense) (27,647) (45,273) Income before income taxes 4,035,369 4,608,419 Income tax (expense) benefit (357,722) (417,878) Net income 3,677,647 4,190,541 Other Comprehensive income - foreign currency translation adjustments 87,491 1,745,242 Comprehensive income $3,765,138 $5,935,783 Basic and Diluted Earnings per Share $0.09 $0.11 Basic and Diluted Weighted-Average Shares Outstanding 42,278,938 37,278,938 CHINA PHARMA HOLDINGS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) March 31, December 31, 2009 2008 ASSETS Current Assets: Cash and cash equivalents $5,151,882 $6,927,149 Trade accounts receivable, less allowance for doubtful accounts of $5,248,353 and $4,474,175, respectively 41,046,443 36,008,095 Other receivables, less allowance fo
'/>"/>
SOURCE China Pharma Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Vivakor Announces New Acquisition Strategy 2Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences 56115 1Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences 56115 2Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 1Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 2Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 1Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 2Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 3Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 4